156 related articles for article (PubMed ID: 25114322)
21. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
Hustig A; Bell C; Waddell R
Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
[TBL] [Abstract][Full Text] [Related]
22. Treatment of gonococcal infections with a single 250 mg intramuscular injection of trospectomycin sulphate vs ceftriaxone sodium.
Mroczkowski TF; Millikan LE; Martin DH; Leonik KJ
Drugs Exp Clin Res; 1993; 19(1):41-6. PubMed ID: 8223139
[TBL] [Abstract][Full Text] [Related]
23. Failure of azithromycin 2.0 g in the treatment of gonococcal urethritis caused by high-level resistance in California.
Gose SO; Soge OO; Beebe JL; Nguyen D; Stoltey JE; Bauer HM
Sex Transm Dis; 2015 May; 42(5):279-80. PubMed ID: 25868141
[TBL] [Abstract][Full Text] [Related]
24. Microbiological efficacy and tolerability of a single-dose regimen of 1 g of ceftriaxone in men with gonococcal urethritis.
Ito S; Yasuda M; Hatazaki K; Mizutani K; Tsuchiya T; Yokoi S; Nakano M; Deguchi T
J Antimicrob Chemother; 2016 Sep; 71(9):2559-62. PubMed ID: 27246232
[TBL] [Abstract][Full Text] [Related]
25. [Neisseria gonorrhoeae: antimicrobial resistance and study of population dynamics. Situation in Barcelona in 2011].
Serra-Pladevall J; Barberá-Gracia MJ; Roig-Carbajosa G; Juvé-Saumell R; Gonzalez-Lopez JJ; Bartolomé-Comas R; Andreu-Domingo A
Enferm Infecc Microbiol Clin; 2013 Nov; 31(9):579-83. PubMed ID: 23623686
[TBL] [Abstract][Full Text] [Related]
26. Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea.
McCormack WM; Mogabgab WJ; Jones RB; Hook EW; Wendel GD; Handsfield HH
Sex Transm Dis; 1993; 20(5):269-73. PubMed ID: 8235924
[TBL] [Abstract][Full Text] [Related]
27. Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.
Brittain C; Childs M; Duley L; Harding J; Hepburn T; Meakin G; Montgomery AA; Tan W; Ross JD
Trials; 2016 Nov; 17(1):558. PubMed ID: 27881151
[TBL] [Abstract][Full Text] [Related]
28. Single-dose treatment of male patients with gonococcal urethritis using 2g spectinomycin: microbiological and clinical evaluations.
Kojima M; Masuda K; Yada Y; Hayase Y; Muratani T; Matsumoto T
Int J Antimicrob Agents; 2008 Jul; 32(1):50-4. PubMed ID: 18539003
[TBL] [Abstract][Full Text] [Related]
29. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.
Y Chen M; Stevens K; Tideman R; Zaia A; Tomita T; Fairley CK; Lahra M; Whiley D; Hogg G
J Antimicrob Chemother; 2013 Jun; 68(6):1445-7. PubMed ID: 23390207
[No Abstract] [Full Text] [Related]
30. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837
[TBL] [Abstract][Full Text] [Related]
31. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
[TBL] [Abstract][Full Text] [Related]
32. Tracing subsequent dissemination of a cluster of gonococcal infections caused by an ST1407-related clone harbouring mosaic penA alleles in Taiwan.
Chen CC; Yen MY; Wong WW; Li LH; Huang YL; Chen KW; Li SY
J Antimicrob Chemother; 2013 Jul; 68(7):1567-71. PubMed ID: 23508619
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.
Cámara J; Serra J; Ayats J; Bastida T; Carnicer-Pont D; Andreu A; Ardanuy C
J Antimicrob Chemother; 2012 Aug; 67(8):1858-60. PubMed ID: 22566592
[TBL] [Abstract][Full Text] [Related]
34. Delaying the widespread emergence of cephalosporin-resistant gonorrhoea: what is the best target?
Tuddenham S; Ghanem KG
Sex Transm Infect; 2015 Jun; 91(4):232-3. PubMed ID: 25990778
[No Abstract] [Full Text] [Related]
35. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group.
Handsfield HH; McCormack WM; Hook EW; Douglas JM; Covino JM; Verdon MS; Reichart CA; Ehret JM
N Engl J Med; 1991 Nov; 325(19):1337-41. PubMed ID: 1922235
[TBL] [Abstract][Full Text] [Related]
36. Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone.
Chisholm SA; Unemo M; Quaye N; Johansson E; Cole MJ; Ison CA; Van de Laar MJ
Euro Surveill; 2013 Jan; 18(3):. PubMed ID: 23351652
[TBL] [Abstract][Full Text] [Related]
37. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins.
Tapsall JW
Curr Opin Infect Dis; 2009 Feb; 22(1):87-91. PubMed ID: 19532086
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women.
Collier AC; Judson FN; Murphy VL; Leach LA; Root CJ; Handsfield HH
Am J Med; 1984 Oct; 77(4C):68-72. PubMed ID: 6093523
[TBL] [Abstract][Full Text] [Related]
39. High incidence of treatment failure of Neisseria gonorrhoeae isolates to ciprofloxacin in male gonococcal urethritis in Delhi.
Chowdhry S; Pandhi D; Vidhani S; Bhalla P; Reddy BS
Int J STD AIDS; 2002 Aug; 13(8):564-7. PubMed ID: 12194741
[TBL] [Abstract][Full Text] [Related]
40. One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia.
Read PJ; Limnios EA; McNulty A; Whiley D; Lahra MM
Sex Health; 2013 Nov; 10(5):460-2. PubMed ID: 24028864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
